TTK Healthcare Limited has completed the transmission of shares from two deceased promoters to their legal heirs, marking the conclusion of a regulatory process that began following the deaths of key promoter group members.

Share Transmission Details

The company announced on December 29, 2025, that it has received intimation regarding the transmission of equity shares held by the deceased promoters. The transmission involves a total of 7,73,298 shares being transferred to three legal heirs:

*Minor represented by her mother and natural guardian Mrs. Maitri Gopalakrishna

Regulatory Compliance and Classification Changes

Following the transmission, TTK Healthcare has made several regulatory disclosures under SEBI LODR Regulations. Ms. Sarayu Thiruvallur Thattai will now be classified as a person belonging to the Promoter Group in accordance with Regulation 31A(6)(a).

Under Regulation 31A(6)(c), both Late Thiruvallur Thattai Jagannathan and Late Thiruvallur Thattai Venkatesh will cease to be classified as Promoter and Promoter Group members, respectively.

Updated Shareholding Pattern

The company has confirmed that the updated and accurate Promoter and Promoter Group shareholding will be reflected in the Shareholding Pattern for the quarter ending December 31, 2025. This transmission process ensures continuity in the company's ownership structure while maintaining compliance with regulatory requirements.

The completion of this transmission process represents a significant milestone in TTK Healthcare's corporate governance, providing clarity on the promoter group composition following the earlier announced deaths of the promoter group members.

TTK Healthcare Limited , a prominent player in the healthcare sector, has recently received income tax orders that could potentially impact its financial position. The company has disclosed that it plans to challenge these orders through the appropriate legal channels.

Income Tax Orders Details

The Income Tax Department has issued two significant orders to TTK Healthcare:

1. For the Assessment Year 2016-17:

   • Withdrawal of interest granted under Section 244A of the Income Tax Act, amounting to ₹1,26,41,187
   • Charging of interest under Section 234D amounting to ₹13,27,355
   • Total impact: ₹1,39,68,542

2. For the Assessment Year 2017-18:

   • Withdrawal of interest granted under Section 244A of the Income Tax Act, amounting to ₹87,62,620

The cumulative financial implication of these orders stands at ₹2,27,31,162.

Company's Response

TTK Healthcare has stated its intention to file appeals against these orders before the appropriate authorities. The company has expressed confidence in obtaining the necessary relief through the appeal process.

Regulatory Compliance

In compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, TTK Healthcare has promptly disclosed this information to the stock exchanges. The company received these orders on August 26, and immediately informed the BSE Limited and the National Stock Exchange of India Limited.

Market Impact

While the immediate financial implication is clear, the long-term impact on TTK Healthcare's financials will depend on the outcome of the appeals process. Investors and stakeholders will likely keep a close watch on the developments in this matter.

TTK Healthcare continues to operate its business as usual while it prepares to address these tax-related challenges through the appropriate legal channels.